Exemestane Aromasin And Letrozole Femara Listings Extended To Early Breast Cancer In Postmenopausal Women

Exemestane Aromasin And Letrozole Femara Listings Extended To Early Breast Cancer In Postmenopausal Women. As the guidelines say, both tamoxifen and aromatase inhibitors can cause side effects. See full list on breastcancer.org

Breast Cancer Drugs Stop Working When Tumors Make Their ...
Breast Cancer Drugs Stop Working When Tumors Make Their ... from breastcancer-news.com
Letrozole) were shown to be more effective at reducing recurrence risk in postmenopausal women and are now used more often than tamoxifen to treat women who’ve gone through menopause. If your doctor doesn’t recommend extended hormonal therapy treatment for you, it’s a good idea to ask why. Hormonal therapy medicines work in two ways:

By lowering the amount of estrogen in the body 2.

In the early 2000s, the aromatase inhibitors: Tamoxifen can be used to treat both premenopausal and postmenopausal women. See full list on breastcancer.org Which is better aromasin or femara for breast cancer?


Post a Comment for "Exemestane Aromasin And Letrozole Femara Listings Extended To Early Breast Cancer In Postmenopausal Women"